Effects of the transtheoretical model-based self-management program on behavioral change in persons with epilepsy: Study protocol for a randomized controlled trial.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
    • Abstract:
      Introduction: Self-management applications are cost-effective and scalable for epilepsy treatment. However, there is a limited long-term quantitative evidence regarding their effectiveness. The Transtheoretical Model (TTM) offers a psychological framework that tailors self-management plans to the individual's stage of behavioral change. This approach aims to address utilization needs, reduce information overload, minimize the adverse effects of self-management, and enhance the overall effectiveness of interventions for individuals with epilepsy.
      Methods and Analysis: This will be a randomized, double-blind, the clinical trial involving two groups of adults diagnosed with epilepsy. In addition to treatment as usual (TAU), the intervention group will receive an intervention program constructed from TTM combined with self-management as part of the treatment plan. The control group will receive TAU only. Prior to the intervention, the participants will undergo an initial assessment to determine their current stage of behavioral change to facilitate the implementation of targeted behavior support strategies. Additionally, participants will receive weekly 30-minute educational videos on epilepsy. The goal is to enroll 160 adults who have been diagnosed with epilepsy for at least six months and are receiving medication. Data collection will encompass an assessment of C-ESMS, HADS, QOLIE-31, and LSSS. These parameters will be evaluated at baseline, as well as during follow-up periods at 1, 3, and 6 months post-intervention.
      Discussion: Existing self-management interventions for people with epilepsy primarily focus on knowledge and psychological factors. Discrepancies in research design, intervention plans, and patient characteristics have contributed to inconsistent outcomes in previous studies. This study seeks to advance the field by integrating the TTM with empirically supported self-management practices. The delineation of behavioral change stages within the TTM framework is expected to form a structured intervention protocol. This study will inform standardized, evidence-based epilepsy care practices.
      Competing Interests: The authors have declared that no competing interests exist.
      (Copyright: © 2024 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
    • References:
      Behav Res Methods. 2009 Nov;41(4):1149-60. (PMID: 19897823)
      BMC Neurol. 2017 Jun 17;17(1):114. (PMID: 28623909)
      J Adv Nurs. 2019 Dec;75(12):3554-3565. (PMID: 31441525)
      Epilepsy Behav. 2011 Mar;20(3):545-9. (PMID: 21333607)
      Am J Prev Med. 2017 Mar;52(3 Suppl 3):S241-S245. (PMID: 28215372)
      PLoS One. 2020 Jan 23;15(1):e0227854. (PMID: 31971965)
      BMJ. 2013 Jan 08;346:e7586. (PMID: 23303884)
      PLoS One. 2022 Dec 15;17(12):e0278907. (PMID: 36520790)
      Epilepsia. 2010 Jun;51(6):1069-77. (PMID: 19889013)
      Epilepsy Behav. 2012 Oct;25(2):150-5. (PMID: 23032121)
      Lancet. 2019 Feb 16;393(10172):689-701. (PMID: 30686584)
      Diabetes Educ. 2013 Sep-Oct;39(5):705-13. (PMID: 23782622)
      Clin Rehabil. 2021 May;35(5):629-638. (PMID: 33225721)
      Epilepsia. 2015 Mar;56(3):460-72. (PMID: 25630353)
      Epilepsy Res. 1991 Apr;8(3):245-51. (PMID: 1868824)
      Addict Behav. 1995 May-Jun;20(3):299-320. (PMID: 7653313)
      Epilepsia. 2002 May;43(5):539-49. (PMID: 12027917)
      Epilepsy Behav. 2015 Sep;50:55-60. (PMID: 26119621)
      Epilepsy Res. 2018 Aug;144:43-48. (PMID: 29775849)
      Ann Behav Med. 2003 Aug;26(1):1-7. (PMID: 12867348)
      Epilepsia. 2007 Dec;48(12):2336-44. (PMID: 17662062)
      Diabetes Metab Syndr. 2019 Jan - Feb;13(1):402-407. (PMID: 30641733)
      Seizure. 2004 Sep;13(6):425-33. (PMID: 15276147)
      Front Public Health. 2015 Apr 27;2:234. (PMID: 25964925)
      Epilepsy Behav. 2017 Apr;69:7-11. (PMID: 28219044)
      Curr Neurol Neurosci Rep. 2007 Jul;7(4):335-41. (PMID: 17618541)
      Epilepsia. 2015 Aug;56(8):1264-74. (PMID: 26122460)
      Pain. 2000 Jun;86(3):255-264. (PMID: 10812255)
      J Consult Clin Psychol. 1991 Apr;59(2):295-304. (PMID: 2030191)
      Epilepsy Behav. 2016 Nov;64(Pt A):152-159. (PMID: 27743547)
      Epilepsy Behav. 2014 Feb;31:187-93. (PMID: 24440688)
      Ann Intern Med. 2019 Jul 16;171(2):117-126. (PMID: 31261386)
      J Child Neurol. 2019 Oct;34(11):666-673. (PMID: 31156013)
      Health Psychol. 1993 Sep;12(5):399-405. (PMID: 8223364)
      Epilepsia. 1998 Jan;39(1):81-8. (PMID: 9578017)
      Epilepsia. 2014 Apr;55(4):475-82. (PMID: 24730690)
      Syst Rev. 2020 Apr 25;9(1):92. (PMID: 32334641)
      J Psychosom Res. 1997 Jan;42(1):17-41. (PMID: 9055211)
      Prog Behav Modif. 1992;28:183-218. (PMID: 1620663)
    • Publication Date:
      Date Created: 20241125 Date Completed: 20241125 Latest Revision: 20241209
    • Publication Date:
      20241210
    • Accession Number:
      PMC11588227
    • Accession Number:
      10.1371/journal.pone.0305547
    • Accession Number:
      39585910